Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311474517> ?p ?o ?g. }
- W4311474517 endingPage "106999" @default.
- W4311474517 startingPage "106999" @default.
- W4311474517 abstract "EZH2 mutations in myeloid neoplasms are loss of function type, and have been linked to poor overall survival (OS) in patients with myelodysplastic syndrome (MDS). However, the specific determinants of outcomes in EZH2-mutant (mut) MDS are not well characterized. In this single-center retrospective study, clinical and genomic data were collected on 1774 patients with MDS treated at Moffitt Cancer Center. In our cohort, 83 (4.7%) patients had a pathogenic EZH2 mutation. Patients with EZH2mut MDS were older than EZH2-wild type (wt) group (median age- 72 vs. 69 years, p = 0.010). The most common co-occurring mutation in EZH2mut MDS was ASXL1, with a significantly higher frequency than EZH2wt (54% vs. 19%, p < 0.001). Patients with EZH2mut MDS had lower response rates to hypomethylating agents compared to EZH2wt MDS (26% vs. 39%; p = 0.050). Median OS of patients with EZH2mut MDS was 30.8 months, with a significantly worse OS than EZH2wt group (35.5 vs. 61.2 months, p = 0.003) in the lower-risk IPSS-R categories. Among patients with EZH2mut MDS, co-presence of ASXL1 or RUNX1 mutations was associated with inferior median OS compared to their wt counterparts (26.8 vs. 48.7 months, p = 0.031). Concurrent chromosome 7 abnormalities (12%) were also associated with significantly worse OS (median OS- 20.8 vs. 35.5 months, p = 0.002) in EZH2mut MDS. Future clinical trials should explore the potential role of novel targeted therapies in improving outcomes in patients with EZH2mut MDS." @default.
- W4311474517 created "2022-12-26" @default.
- W4311474517 creator A5010075752 @default.
- W4311474517 creator A5022353898 @default.
- W4311474517 creator A5029369362 @default.
- W4311474517 creator A5036071264 @default.
- W4311474517 creator A5040675080 @default.
- W4311474517 creator A5041443589 @default.
- W4311474517 creator A5041754278 @default.
- W4311474517 creator A5047282995 @default.
- W4311474517 creator A5047764826 @default.
- W4311474517 creator A5057933586 @default.
- W4311474517 creator A5061883803 @default.
- W4311474517 creator A5073057060 @default.
- W4311474517 creator A5076396878 @default.
- W4311474517 date "2023-01-01" @default.
- W4311474517 modified "2023-09-26" @default.
- W4311474517 title "Clinical characteristics and outcomes of EZH2-mutant myelodysplastic syndrome: A large single institution analysis of 1774 patients" @default.
- W4311474517 cites W1484425575 @default.
- W4311474517 cites W1928159695 @default.
- W4311474517 cites W1963736125 @default.
- W4311474517 cites W1992915563 @default.
- W4311474517 cites W1993236149 @default.
- W4311474517 cites W2015132841 @default.
- W4311474517 cites W2016644845 @default.
- W4311474517 cites W2024373518 @default.
- W4311474517 cites W2046540572 @default.
- W4311474517 cites W2070152906 @default.
- W4311474517 cites W2079671946 @default.
- W4311474517 cites W2094051261 @default.
- W4311474517 cites W2123355582 @default.
- W4311474517 cites W2129510594 @default.
- W4311474517 cites W2138712261 @default.
- W4311474517 cites W2147370638 @default.
- W4311474517 cites W2159249303 @default.
- W4311474517 cites W2161841622 @default.
- W4311474517 cites W2171439874 @default.
- W4311474517 cites W2264682687 @default.
- W4311474517 cites W2271837396 @default.
- W4311474517 cites W2273962941 @default.
- W4311474517 cites W2326726820 @default.
- W4311474517 cites W2339658711 @default.
- W4311474517 cites W2435453758 @default.
- W4311474517 cites W2543307778 @default.
- W4311474517 cites W2607299002 @default.
- W4311474517 cites W2624693218 @default.
- W4311474517 cites W2737586525 @default.
- W4311474517 cites W2756901145 @default.
- W4311474517 cites W2967535502 @default.
- W4311474517 cites W2983431477 @default.
- W4311474517 doi "https://doi.org/10.1016/j.leukres.2022.106999" @default.
- W4311474517 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36542963" @default.
- W4311474517 hasPublicationYear "2023" @default.
- W4311474517 type Work @default.
- W4311474517 citedByCount "0" @default.
- W4311474517 crossrefType "journal-article" @default.
- W4311474517 hasAuthorship W4311474517A5010075752 @default.
- W4311474517 hasAuthorship W4311474517A5022353898 @default.
- W4311474517 hasAuthorship W4311474517A5029369362 @default.
- W4311474517 hasAuthorship W4311474517A5036071264 @default.
- W4311474517 hasAuthorship W4311474517A5040675080 @default.
- W4311474517 hasAuthorship W4311474517A5041443589 @default.
- W4311474517 hasAuthorship W4311474517A5041754278 @default.
- W4311474517 hasAuthorship W4311474517A5047282995 @default.
- W4311474517 hasAuthorship W4311474517A5047764826 @default.
- W4311474517 hasAuthorship W4311474517A5057933586 @default.
- W4311474517 hasAuthorship W4311474517A5061883803 @default.
- W4311474517 hasAuthorship W4311474517A5073057060 @default.
- W4311474517 hasAuthorship W4311474517A5076396878 @default.
- W4311474517 hasConcept C104317684 @default.
- W4311474517 hasConcept C126322002 @default.
- W4311474517 hasConcept C143998085 @default.
- W4311474517 hasConcept C150194340 @default.
- W4311474517 hasConcept C167135981 @default.
- W4311474517 hasConcept C190727270 @default.
- W4311474517 hasConcept C2780007613 @default.
- W4311474517 hasConcept C2780073493 @default.
- W4311474517 hasConcept C2780235182 @default.
- W4311474517 hasConcept C2780817109 @default.
- W4311474517 hasConcept C33288867 @default.
- W4311474517 hasConcept C50171091 @default.
- W4311474517 hasConcept C54355233 @default.
- W4311474517 hasConcept C71924100 @default.
- W4311474517 hasConcept C72563966 @default.
- W4311474517 hasConcept C86803240 @default.
- W4311474517 hasConcept C90924648 @default.
- W4311474517 hasConceptScore W4311474517C104317684 @default.
- W4311474517 hasConceptScore W4311474517C126322002 @default.
- W4311474517 hasConceptScore W4311474517C143998085 @default.
- W4311474517 hasConceptScore W4311474517C150194340 @default.
- W4311474517 hasConceptScore W4311474517C167135981 @default.
- W4311474517 hasConceptScore W4311474517C190727270 @default.
- W4311474517 hasConceptScore W4311474517C2780007613 @default.
- W4311474517 hasConceptScore W4311474517C2780073493 @default.
- W4311474517 hasConceptScore W4311474517C2780235182 @default.
- W4311474517 hasConceptScore W4311474517C2780817109 @default.
- W4311474517 hasConceptScore W4311474517C33288867 @default.
- W4311474517 hasConceptScore W4311474517C50171091 @default.